Skip to main content
Clinical Trials/NCT04021888
NCT04021888
Unknown
Not Applicable

The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease

Dokuz Eylul University1 site in 1 country60 target enrollmentJuly 16, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer Disease
Sponsor
Dokuz Eylul University
Enrollment
60
Locations
1
Primary Endpoint
Change in cognition
Last Updated
6 years ago

Overview

Brief Summary

The primary aim of this trial is to investigate the feasibility of an exercise program consisting of respiratory exercises, aerobic exercises and strengthening exercises in mild to moderate Alzheimer's disease. The trial also aims to investigate the effectiveness of the exercise program on respiratory symptoms, exercise capacity, cognition, physical performance, depression, sleepiness, activities of daily living and quality of life.

Patients will be divided into exercise (intervention) and control group by randomization method. The study is planned to be performed with a total of 60 patients, 30 in each group. The patients in the exercise group will be given breathing exercises aerobic exercises and strengthening exercises for 2 days a week for 12 weeks, about 30-40 minutes while the patients in the control group will be provided with suggestions, home exercise program and daily life activities

Detailed Description

Exercise group was trained 3 times a week under the supervision of a physiotherapist and encouraged to exercise at home on other days

Registry
clinicaltrials.gov
Start Date
July 16, 2018
End Date
July 30, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Elvan Keles

Research Assistant

Dokuz Eylul University

Eligibility Criteria

Inclusion Criteria

  • aged over 65 years
  • can walk independent

Exclusion Criteria

  • can't see
  • have done any exercise in the last 6 months
  • have a major and uncontrolled orthopedic, neurological or cardiopulmonary problem that restricts functioning
  • having non Alzheimer's disease dementia

Outcomes

Primary Outcomes

Change in cognition

Time Frame: Baseline, 12th week

The Mini-Mental State Examination (MMSE) is used to measure cognitive impairment in older adults. It assesses different subset of cognitive status including attention, language, memory, orientation, visuospatial proficiency.

Secondary Outcomes

  • Change in pulmonary functions(Baseline, 12th week)
  • Change in respiratory muscle strength(Baseline, 12th week)
  • Change in functional capacity(Baseline, 12th week)
  • Change in physical performance(Baseline, 12th week)
  • Change in sleepiness(Baseline, 12th week)
  • Change in quality of life(Baseline, 12th week)
  • Change in activities of daily living(Baseline, 12th week)
  • Change in depression(Baseline, 12th week)
  • Change in muscle strength(Baseline, 12th week)

Study Sites (1)

Loading locations...

Similar Trials